Assessment of serum and salivary lactate dehydrogenase and uric acid levels in oral squamous cell carcinoma patients
Keywords:
oral cancer, lactate dehydrogenase, Uric acidAbstract
Background: The present study was conducted to assess serum and salivary lactate dehydrogenase and uric acid levels in oral squamous cell carcinoma patients. Materials & Methods: 62 patients of oral squamous cell carcinoma patients of both genders were enrolled. Patients were divided into two groups. Group I had SCC patients and group II had normal subjects. In all, serum and unstimulated saliva samples obtained and subjected to assessment of lactate dehydrogenase and uric acid levels. Results: The mean serum LDH level (U/L) in group I was 342.8 and in group II was 246.0. The mean salivary LDH level (U/L) in group I was 652.8 and in group II was 248.4. The difference was significant (P< 0.05). The mean serum uric acid (mg/dl) in group I was 6.98 and in group II was 5.12. The mean salivary uric acid in group I was 5.92 and in group II was 5.26. The difference was significant (P< 0.05). Conclusion: OSCC patients had elevated level of serum and salivary LDH and uric acid.
Downloads
References
Suh SY, Ahn HY. Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: A preliminary study. Eur J Cancer 2007;43:1051 9.
Zhou GQ, RenXY, Mao YP, Chen L, Sun Y, Liu LZ, et al. Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity modulated radiotherapy. Sci Rep 2016;6:22326.
Joshi PS, Chougule M, Dudanakar M, Golgire S. Comparison between salivary and serum lactate dehydrogenase levels in patients with oral leukoplakia and oral squamous cell carcinoma — A pilot study. Int J Oral Maxillofac Pathol2012;3:7 13.
Anuradha CD, Devi CS. Studies on enzymes of clinical significance in oral sub mucous fi brosis. J Clin Biochem Nutr 1998;24:45 52.
Kamath VV, Satelur K, Komali Y. Biochemical markers in oral sub mucous fibrosis: A review and update. Dent Res J 2013;10:576 84.
Nagler RM, Lischinsky S, Diamond E, Klein I, Reznick AZ. New insightsinto salivary lactate dehydrogenase of human subjects. J Lab Clin Med 2001;137:363 9.
Achalli S, Babu S, Bhat S, Chadha R, Kumari S, Shetty SR. Salivary lactate dehydrogenase levels in oral leucoplakia and oral squamous cell carcinoma: A biochemical andclinicopathological study. J Cancer Res Ther 2012;8:123 5.
Metgud R, Patel S. Estimation of salivary lactate dehydrogenase in oral leukoplakia and oral squamous cell carcinoma: A biochemical study. J Cancer Res Ther 2015;11:119 23.
Pereira T, Pereira S, Shetty S. Estimation of serum lactate dehydrogenase level in patients with oral premalignant lesions/conditions and oral squamous cell carcinoma: A clinicopathological study. J Cancer Res Ther 2015;11:78 82.
Anitha G, Kumar KV, Deshpande G, Nagaraj M, Kalyani V. Utility of serum and salivary lactate dehydrogenase and uric acid levels as a diagnostic profile in oral squamous cell carcinoma patients. J Oral Maxillofac Pathol 2022;26:218-27.
Gholizadeh N, Alipanahi Ramandi M, Motiee-Langroudi M, Jafari M, Sharouny H, Sheykhbahaei N. Serum and salivary levels of lactate dehydrogenase in oral squamous cell carcinoma, oral lichen planus and oral lichenoid reaction. BMC Oral Health. 2020 Dec;20(1):1-8.
Dhankhar R, Dahiya K, Sharma TK, Ghalaut VS, Atri R, Kaushal V. Diagnostic significance of adenosine deaminase, uric acid and C reactive protein levels in patients of head and neck carcinoma. Clin Lab 2011;57:795 8.
Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202
Akbarov, A. N., & Xabilov, D. N. U. (2021). The condition of the oral cavity in patients who have had a viral infection COVID-19. International Journal of Health & Medical Sciences, 4(4), 381-383. https://doi.org/10.21744/ijhms.v4n4.1796
Published
How to Cite
Issue
Section
Copyright (c) 2021 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
